USA: Postdoctoral fellowship in TSE/Prion Molecular Biology at NIH
Description: A postdoctoral fellowship position is available in the TSE/Prion Molecular Biology Section of the Laboratory of Persistent Viral Diseases in the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, located at Rocky Mountain Laboratories (RML) in Hamilton, MT. This section uses in vivo and in vitro models to study the molecular mechanisms underlying prion pathogenesis and to identify effective anti-prion drugs. The section uses both human and rodent models to determine how prions establish an infection and how prion protein misfolding determines disease phenotypes. The section also studies amyloid and non-amyloid forms of prion disease to elucidate general mechanisms of protein misfolding and spread that may be applicable to other protein misfolding diseases such as Alzheimer’s and Parkinson’s disease.
RML offers state-of-the-art facilities for genomics, proteomics, DNA microarray, and biological imaging in a recently renovated laboratory. The laboratory is located in the scenic Bitterroot Valley of western Montana, with easy access to some of the finest outdoor recreational opportunities in North America. In 2010, RML was ranked 6th in The Scientist magazine’s survey of the Best Places To Work for postdoctoral research fellows.
Starting stipends range from $44,000 to $50,400 per year, depending on experience, and health benefits are provided. Preference will be given to those candidates with experience and a background in molecular pathogenesis and animal models of infection.
Eligibility: Applicants must hold a Ph.D., D.V.M., or M.D. To apply, send curriculum vitae and three letters of reference to Suzette A. Priola, Ph.D., Senior Investigator and Chief, TSE/Prion Molecular Biology Section, NIH/NIAID, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT 59840 or email spriolanih.gov.
To learn more: about NIAID and how you can play a role in this exciting and dynamic research organization, visit us on the Web; subscribe to email updates; and follow us on Twitter, LinkedIn, and Facebook.